- Home
- CRBU vs ODYS Comparison
CRBU vs ODYS Comparison
Compare CRBU & ODYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- ODYS
- Stock Information
- Founded
- CRBU 2011
- ODYS N/A
- Country
- CRBU United States
- ODYS Israel
- Employees
- CRBU N/A
- ODYS N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- ODYS
- Sector
- CRBU Health Care
- ODYS
- Exchange
- CRBU Nasdaq
- ODYS NYSE
- Market Cap
- CRBU 93.0M
- ODYS 86.1M
- IPO Year
- CRBU 2021
- ODYS N/A
- Fundamental
- Price
- CRBU $1.06
- ODYS $5.40
- Analyst Decision
- CRBU Strong Buy
- ODYS Strong Buy
- Analyst Count
- CRBU 4
- ODYS 1
- Target Price
- CRBU $8.50
- ODYS $10.00
- AVG Volume (30 Days)
- CRBU 943.1K
- ODYS 10.9K
- Earning Date
- CRBU 05-08-2025
- ODYS 05-15-2025
- Dividend Yield
- CRBU N/A
- ODYS N/A
- EPS Growth
- CRBU N/A
- ODYS N/A
- EPS
- CRBU N/A
- ODYS N/A
- Revenue
- CRBU $9,918,000.00
- ODYS $5,842,000.00
- Revenue This Year
- CRBU N/A
- ODYS N/A
- Revenue Next Year
- CRBU $161.81
- ODYS N/A
- P/E Ratio
- CRBU N/A
- ODYS N/A
- Revenue Growth
- CRBU N/A
- ODYS 100.27
- 52 Week Low
- CRBU $0.66
- ODYS $5.01
- 52 Week High
- CRBU $3.00
- ODYS $10.80
- Technical
- Relative Strength Index (RSI)
- CRBU 56.92
- ODYS N/A
- Support Level
- CRBU $0.98
- ODYS N/A
- Resistance Level
- CRBU $1.21
- ODYS N/A
- Average True Range (ATR)
- CRBU 0.10
- ODYS 0.00
- MACD
- CRBU 0.02
- ODYS 0.00
- Stochastic Oscillator
- CRBU 65.99
- ODYS 0.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About ODYS ODYSIGHT AI INC
Odysight ai Inc is engaged in the development, production, and marketing of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries.